Edmond L. Schmulbach

Hematology Oncology | Hematology | Oncology
South San Francisco, CA 94080

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211).

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 19, 2022
Showing 1-1 of 1

Last Updated: 09/26/2026